drugset / Trial / NCT02552667

Efficacy and Safety of HCP1102 Capsule

NCT02552667

Phase 3 Completed 228 enrolled Hanmi Pharmaceutical Company Limited
RandomizedParallel-groupDouble-blindTreatment

Summary

Efficacy and safety of HCP1102 capsule : A randomized, double-blind, active-controlled, multicenter phase 3 clinical trial.

Timeline

Start
2014-09
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject HCP1102 Unknown 10 mg
Comparator HGP0711 Unknown 5 mg